“…Once the under funding of the system is admitted, one also expects to find problems in drugs offer, not only regarding availability, but also in relation to the rationality of use and management of pharmaceutical services. These problems were confirmed by some studies in the last few years (PAN-AMERICAN HE-ALTH ORGANIZATION et al, 2005;WORLD BANK, 2007;VIEIRA, 2008).…”